These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18497248)

  • 61. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Metformin and intravascular contrast media. National guidelines 2001-03-16].
    Lakartidningen; 2001 Apr; 98(16):1935-6. PubMed ID: 11370412
    [No Abstract]   [Full Text] [Related]  

  • 63. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
    Barba M; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
    [No Abstract]   [Full Text] [Related]  

  • 64. Follow-up of intensive glucose control in type 2 diabetes.
    Petrie JR
    N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
    [No Abstract]   [Full Text] [Related]  

  • 65. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 68. Heart failure and diabetes mellitus: epidemiology and management of an alarming association.
    Cohen-Solal A; Beauvais F; Logeart D
    J Card Fail; 2008 Sep; 14(7):615-25. PubMed ID: 18722328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Taneja SS
    J Urol; 2014 Jun; 191(6):1783. PubMed ID: 25280280
    [No Abstract]   [Full Text] [Related]  

  • 70. Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Weckermann D
    Eur Urol; 2014 Jul; 66(1):174-5. PubMed ID: 24929079
    [No Abstract]   [Full Text] [Related]  

  • 71. Hyperinsulinaemia and iron perturbation in patients with type 2 diabetes.
    Mascitelli L; Pezzetta F; Goldstein MR
    Int J Clin Pract; 2009 Apr; 63(4):672. PubMed ID: 19335710
    [No Abstract]   [Full Text] [Related]  

  • 72. Metformin as Initial Oral Therapy in Type 2 Diabetes.
    Stern RJ; Murphy EJ
    JAMA; 2015 Jun 23-30; 313(24):2484-5. PubMed ID: 26103032
    [No Abstract]   [Full Text] [Related]  

  • 73. Therapies for type 2 diabetes and coronary artery disease.
    DeVries JH
    N Engl J Med; 2009 Oct; 361(14):1408-9; author reply 1409-10. PubMed ID: 19802918
    [No Abstract]   [Full Text] [Related]  

  • 74. Heeding clues to metformin-associated lactic acidosis: prompt response can save life.
    Kumar U; Chennavir B; Gopi A
    Emerg Med J; 2008 Aug; 25(8):537-8. PubMed ID: 18660415
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Type 2 diabetes: Metformin: first choice at the start of therapy].
    Gallwitz B
    Dtsch Med Wochenschr; 2015 Feb; 140(4):236. PubMed ID: 25704514
    [No Abstract]   [Full Text] [Related]  

  • 76. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [What Is the effect of metformin combined to chemotherapy in stage IV colorectal cancer with diabetes?].
    Jung JT
    Korean J Gastroenterol; 2012 Dec; 60(6):343-4. PubMed ID: 23367542
    [No Abstract]   [Full Text] [Related]  

  • 78. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?
    Zanders MM; Vissers PA; van de Poll-Franse LV
    J Clin Oncol; 2014 Mar; 32(7):701. PubMed ID: 24395861
    [No Abstract]   [Full Text] [Related]  

  • 79. [Pharmacological sheet. Vildagliptin, oral administration (GALVUS)].
    J Pharm Belg; 2009 Jun; (2):64-6. PubMed ID: 19739530
    [No Abstract]   [Full Text] [Related]  

  • 80. A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.
    Cobitz A; Zambanini A; Sowell M; Heise M; Louridas B; McMorn S; Semigran M; Koch G
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):769-81. PubMed ID: 18613278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.